The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry
NCT02530268 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-02-09
Summary
This prospective, non-interventional, research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for PsA-SpA in a cohort of patients cared for by rheumatologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Conditions
- Psoriatic Arthritis
- Spondyloarthritis
Sponsors & Collaborators
-
CorEvitas
lead NETWORK
Principal Investigators
-
Jeffrey Greenberg, MD, MPH · CorEvitas
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2100-12-31
- Completion
- 2100-12-31
More Related Trials
-
Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
NCT01289730 ·Status: UNKNOWN ·Phase: PHASE2
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach
NCT02525042 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)
NCT04428502 ·Status: COMPLETED
-
Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study
NCT01625650 ·Status: COMPLETED
-
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
NCT05479448 ·Status: RECRUITING
-
Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
NCT01118728 ·Status: TERMINATED ·Phase: PHASE2
-
Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
NCT04507776 ·Status: COMPLETED
-
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
NCT00726804 ·Status: TERMINATED ·Phase: PHASE4
-
Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients
NCT04679272 ·Status: COMPLETED
-
Ultrasound Enthesitis Response in Psoriatic Arthritis
NCT03955861 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
NCT00293709 ·Status: COMPLETED
-
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
NCT00245960 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of New Prognostic Markers in Psoriatic Arthritis
NCT03455166 ·Status: COMPLETED ·Phase: NA
-
Study During Pregnancy of Expression of miRNAs in RA or SLE
NCT02350491 ·Status: COMPLETED
-
The Diagnostic Ultrasound Enthesitis Tool (DUET) Study
NCT04587362 ·Status: COMPLETED
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis
NCT00976599 ·Status: COMPLETED ·Phase: PHASE2
-
Rheumatology Biorepository
NCT04899895 ·Status: ENROLLING_BY_INVITATION
-
A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment
NCT03828045 ·Status: COMPLETED
-
Psoriatic Arthritis Treat to Target vs. Usual Care
NCT01692912 ·Status: WITHDRAWN ·Phase: NA
-
Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients
NCT00895050 ·Status: COMPLETED
-
CARNet : Self-Monitoring and Co-driving in Rheumatology With Internet : Rheumatoid Arthritis Cohort (Usual Care Study)
NCT02200068 ·Status: COMPLETED ·Phase: NA